RecruitingNot ApplicableNCT07454174

Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

Short-Term Metabolic Impacts of Ren-Nu: A Dietary Program for Individuals With Polycystic Kidney Disease


Sponsor

Richard Fatica

Enrollment

20 participants

Start Date

Feb 25, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Ren-Nu and KetoCitra for people with autosomal dominant polycystic kidney disease (adpkd. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTRen-Nu and KetoCitra

This is a structured, nutritionist monitored program supplemented with a nutritional food product, while monitoring metabolic parameters


Locations(1)

Cleveland Clinic

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07454174


Related Trials